Latest News
Institutional support, federal funding, philanthropy and grants are the support that make cancer research possible.
- November 28, 2023
Yale Cancer Center researchers at Yale School of Medicine will present new research at the 46th annual San Antonio Breast Cancer Symposium (SABCS) from December 5 to 9.
- October 13, 2023
Qin Yan, PhD, Professor of Pathology, receives Outstanding Investigator Award from the American Society of Investigative Pathology.
- August 03, 2023
A research team co-led by Dr. Katerina Politi found how mSWI/SNF complexes mediate resistance of lung adenocarcinomas to osimertinib and other tyrosine kinase inhibitors.
- August 31, 2022
A new study from Yale Cancer Center scientists has identified the chromatin regulator WDR5 as a possible new drug target in triple negative breast cancer.
- April 11, 2022
The American Society for Investigative Pathology has announced it will honor Qin Yan, PhD, Associate Professor of Pathology at Yale School of Medicine, with its 2023 Outstanding Investigator Award.
- March 02, 2022Source: Yale Daily News
Yale researchers found that the epigenetic regulator gene cat eye syndrome chromosome region candidate 2, or CECR2, is responsible for driving breast cancer metastasis –– making it exponentially more difficult to treat.
- February 21, 2022
Three Yale Pathology faculty members were recently honored for their contributions to cancer research and education during the Yale Cancer Center Annual Conclave on February 15, 2022.
- February 01, 2022
A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing.
- October 20, 2021
A new study led by Yale Cancer Center researchers shows that the enzyme KDM5B suppresses anti-melanoma immunity.